Ralph Alderson
MacroGenics (United States)(US)
Publications by Year
Research Areas
Monoclonal and Polyclonal Antibodies Research, CAR-T cell therapy research, Immunotherapy and Immune Responses, Nerve injury and regeneration, Glycosylation and Glycoproteins Research
Most-Cited Works
- → NT-3, BDNF, and NGF in the developing rat nervous system: Parallel as well as reciprocal patterns of expression(1990)1,235 cited
- → Brain-derived neurotrophic factor increases survival and differentiated functions of rat septal cholinergic neurons in culture(1990)689 cited
- → Detection of brain-derived neurotrophic factor-like activity in fibroblasts and Schwann cells: Inhibition by antibodies to NGF(1991)284 cited
- → Development of an Fc-Enhanced Anti–B7-H3 Monoclonal Antibody with Potent Antitumor Activity(2012)272 cited
- → Expression of Ciliary Neurotrophic Factor and the Neurotrophins – Nerve Growth Factor, Brain‐Derived Neurotrophic Factor and Neurotrophin 3—in Cultured Rat Hippocampal Astrocytes(1992)197 cited
- → Differential distribution of exogenous BDNF, NGF, and NT‐3 in the brain corresponds to the relative abundance and distribution of high‐affinity and low‐affinity neurotrophin receptors(1995)173 cited
- → A CD3xCD123 bispecific DART for redirecting host T cells to myelogenous leukemia: Preclinical activity and safety in nonhuman primates(2015)166 cited
- → CAT-8015: A Second-GenerationPseudomonasExotoxin A–Based Immunotherapy Targeting CD22-Expressing Hematologic Malignancies(2009)103 cited
- → STRL22 Is a Receptor for the CC Chemokine MIP-3α(1997)101 cited
- → Development of PF-06671008, a Highly Potent Anti-P-cadherin/Anti-CD3 Bispecific DART Molecule with Extended Half-Life for the Treatment of Cancer(2016)94 cited